Melatonin for Sleep in MS

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 23, 2019

Primary Completion Date

November 17, 2020

Study Completion Date

November 17, 2020

Conditions
Multiple Sclerosis
Interventions
DIETARY_SUPPLEMENT

Melatonin

Participants will start with 0.5 mg tablets of melatonin with the option of switching to an 'escalation dose' of 3 mg if no relief after 3 days.

DIETARY_SUPPLEMENT

Placebo

Placebo

Trial Locations (1)

94158

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT04035889 - Melatonin for Sleep in MS | Biotech Hunter | Biotech Hunter